George Vasmatzis
Overview
Explore the profile of George Vasmatzis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
144
Citations
3198
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ali M, Riviere-Cazaux C, Johnson S, Salvatori R, Penheiter A, Smadbeck J, et al.
Clin Cancer Res
. 2025 Feb;
PMID: 40019927
Purpose: Monitoring disease progression in patients with high-grade gliomas (HGGs) is challenging due to treatment-related changes on imaging and the requirement for neurosurgical intervention to obtain diagnostic tissue. DNA junctions...
2.
Gagnon M, Tonk S, Carcamo B, Bustamante D, Stein M, Johnson S, et al.
Cancer Genet
. 2025 Feb;
292-293:57-64.
PMID: 39892372
Gene fusions involving NUP98 have been reported in several hematologic malignancies yet have been very rarely reported in B-acute lymphoblastic leukemia (B-ALL). Two cases of B-ALL for which chromosome banding...
3.
Parikh K, Harris F, Karagouga G, Schrandt A, Mandrekar J, Johnson S, et al.
JTO Clin Res Rep
. 2024 Dec;
5(12):100692.
PMID: 39735890
Introduction: The spatially complex nature of mesothelioma and interventions like pleurodesis, surgery, and radiation often complicate imaging-based assessment. Further, cell-free DNA (cfDNA) based monitoring strategies are inadequate for mesothelioma, given...
4.
Wester M, Lim J, Khaertdinova L, Darsi S, Donthamsetti N, Mensing G, et al.
Microsyst Nanoeng
. 2024 Oct;
10(1):147.
PMID: 39414790
Hanging drop cultures provide a favorable environment for the gentle, gel-free formation of highly uniform three-dimensional cell cultures often used in drug screening applications. Initial cell numbers can be limited,...
5.
Pezeshki A, Cheville J, Florio A, Leibovich B, Vasmatzis G
Front Immunol
. 2024 Apr;
15:1356144.
PMID: 38605943
Background: Only 20 percent of renal and bladder cancer patients will show a significant response to immune checkpoint inhibitor (ICI) therapy, and no test currently available accurately predicts ICI response....
6.
Florio A, Johnson S, Salvatori R, Vasmatzis G
Sci Rep
. 2024 Mar;
14(1):7303.
PMID: 38538642
Ex vivo drug screening is a potentially powerful tool for the future of cancer care, but the accuracy of results is contingent on the culture model. Both monolayer (2D) and...
7.
Solanki A, Cornette J, Udell J, Vasmatzis G, Riedel M
IEEE/ACM Trans Comput Biol Bioinform
. 2024 Mar;
21(3):450-460.
PMID: 38427545
The Omicron variants boast the highest infectivity rates among all SARS-CoV-2 variants. Despite their lower disease severity, they can reinfect COVID-19 patients and infect vaccinated individuals as well. The high...
8.
Atkins T, Solanki A, Vasmatzis G, Cornette J, Riedel M
Front Immunol
. 2024 Jan;
14:1288105.
PMID: 38292493
Bias in neural network model training datasets has been observed to decrease prediction accuracy for groups underrepresented in training data. Thus, investigating the composition of training datasets used in machine...
9.
Farris J, Khanna C, Smadbeck J, Johnson S, Bothun E, Kaplan T, et al.
Am J Med Genet A
. 2024 Jan;
194(5):e63542.
PMID: 38234180
Axenfeld-Rieger Syndrome (ARS) type 1 is a rare autosomal dominant condition characterized by anterior chamber anomalies, umbilical defects, dental hypoplasia, and craniofacial anomalies, with Meckel's diverticulum in some individuals. Here,...
10.
Gagnon M, Penheiter A, Harris F, Sadeghian D, Johnson S, Karagouga G, et al.
Blood Cancer J
. 2023 Dec;
13(1):190.
PMID: 38114462
No abstract available.